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How reliable are 
self-measured blood
pressures taken at home?
■ EVIDENCE-BASED ANSWER
Self-measured blood pressures (SMBP) can be
precise and accurate and, thus, reliably be used
as an adjunct to office blood pressure measure-
ments in selected clinical situations (strength of
recommendation [SOR]: B, extrapolation and
limited trials). Clinicians using SMBP need to
be aware of the difference in normal reference
ranges, with pressures greater than 135/85 mm
Hg considered hypertensive. 
Whether hypertensive treatment should be
based primarily on SMBP is unclear, and cur-
rently undergoing study. Clinicians should rec-
ommend multiple daily measurements with a
validated and standardized device, preferably
equipped with memory or transmission capabil-
ities, in order to avoid patient error in transcrib-
ing and reporting values. Wrist or finger devices
cannot reliably be used (SOR: B, limited com-
parison studies). 
■ EVIDENCE SUMMARY
Office blood pressure (OBP) has traditionally
been used in long-term trials to describe the
relationship between blood pressure and cardio-
vascular morbidity and mortality, as well as to
establish the efficacy of antihypertensive drug
therapy. A prospective randomized trial demon-
strating the relationship between therapy based
on SMBP to these same outcomes is in
progress.1
Two large prospective cohort studies of the
relationship between SMBP and morbidity and
mortality made comparative baseline blood
pressure measurements and followed the
cohorts without suggestions or attempts to
change management. The first was a rural pop-
ulation-based study with 1789 subjects (90% of
the population) from Ohasama, Japan.2 Mean fol-
low-up was 6.6 years with less than 1% dropout
rate. The second large cohort study (SHEAF
trial) included patients ≥60 years old with the
diagnosis of hypertension.3 A total of 4939
cases were analyzed. Mean follow-up was 3.2
years with less than 1% dropout rate. Both stud-
ies show that each mm Hg increase in SMBP
was a better predictor of cardiovascular events
than an equivalent increase in OBP (Table 1).
Office blood pressure measurements exhibit
large variability (decreased precision) and are
subject to multiple biases (decreased accuracy).
Self-measured blood pressures at home became
common when “white-coat hypertension” was
recognized to be clinically significant. It allows
for a larger number of measurements for indi-
vidual patients, resulting in greater precision
than OBP.4 SMBP correlates better than OBP
with surrogate measures of hypertensive con-
trol, such as  ambulatory blood pressure meas-
urement5 and left ventricular mass.6 Thus,
SMBP might some day become the gold stan-
dard for defining hypertension in the clinical
setting.  Meanwhile, the correlation between
OBP and SMBP can be derived via three differ-
ent mathematical models using data from multi-
ple studies. The accepted cutoff for SMBP
defined hypertension is 135/85 mm Hg.7
The THOP trial8 was a single-blinded, 
randomized controlled trial of hypertensive
treatment based on SMBP vs OBP. Four hun-
dred patients were randomized to SMBP or OBP,
with medication adjustments made by a blinded
clinician. The trial design called for both treat-
ment groups to be titrated to a diastolic blood
pressure of 80 to 89 mm Hg. The follow-up was
approximately 1 year. Graphical data indicate
that both groups were equally effective in 
meeting the blood pressure goals outlined in the
methods. 
Other differences in outcomes were propor-
tional to the known difference in normotensive
reference ranges (eg, that OBP tend to run high-
er than SMBP). Patients in the SMBP group
were put on less-intensive drug treatment and
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incurred slightly lower medical costs. SMBP
patients were twice as likely to have their blood
pressure medication discontinued, possibly indi-
cating SMBP helped to identify white-coat
hypertension. 
■ RECOMMENDATIONS FROM OTHERS
In addition to diagnosing white-coat hyperten-
sion, World Health Organization/International
Society of Hypertension Guidelines Committee
has recommended that home blood pressure
measurement is useful in the following circum-
stances:9
• unusual variability of blood pressure over the
same or different visits
• office hypertension in subjects with low 
cardiovascular risk
• symptoms suggesting hypotensive episodes
• hypertension resistant to drug treatment.
Standardization and validation protocols are
available from the Association for the
Advancement of Medical Instrumentation,10
European Hypertension Society,11 or the 
British Hypertension Society (available at
www.hyp.ac.uk/bhs/bp_ monitors/automatic.htm).
Relatively few of the hundreds of available
blood pressure measurement devices available
meet these criteria. The most current
Association for the Advancement of Medical
Instrumentation standards are labeled as
ANSI/AAMI-SP10:2002/A1:2003 standards.
Table 2 lists some devices that meet the various
protocols.  Devices in this market change rapid-
ly, so buyers should confirm the device they are
evaluating meets current standards.
James Meza, MD, MSA, Melissa Nayak, MD,
Henry Ford Hospital, Detroit, Mich; Sandra Martin, MLS,
Wayne State University, Detroit, Mich
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Increase in cardiovascular mortality 
for each 1 mm Hg increase in blood pressure
Cox Proportional Relative Hazards Ratio [95 % CI]
Home Home Office Office
systolic BP diastolic BP systolic BP diastolic BP
Ohasama study2* 1.021 1.015 1.005 1.008
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†Increase in cardiovascular events for each 1 mm Hg increase in blood pressure. Results were adjusted for age, sex, heart rate, smoking
status, history of cardiovascular events, presence of diabetes, presence of obesity, and presence of treatment for hypercholesterolemia.
‡Statistically significant.
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■ CLINICAL COMMENTARY
Self-measured BP may help us better 
diagnose and manage hypertension
It has been shown that office blood pressure
readings can give false-positive results in
those who have “white coat hypertension”
and give false-negative readings in those
with “white coat normotension” or “masked
hypertension”—patients who have normal
blood pressure values in the office, but ele-
vated blood pressure values outside the
office. This is not a trivial issue. Ten to 20%
of patients with normal blood pressure values
in the office have elevated blood pressure val-
ues throughout the day, and evidence is
beginning to mount that the cardiovascular
consequences are the same for these patients
as for those with sustained hypertension.1
The SHEAF trial (and other studies) have
thrown another complexity into hypertension
control by showing that OBP readings were
inaccurate in 22% of treated hypertensive
patients—13% had uncontrolled OBP with
normal SMBP, and 9% had normal OBP but
uncontrolled SMBP.3
Thus, SMBP is a potentially very powerful
and cost-effective tool that may help us bet-
ter diagnose and manage this complex dis-
ease. I have encouraged my hypertensive
patients to do SMBP and, as one who has
white-coat hypertension (and a strong family
history of hypertension), I am diligent at tak-
ing my own SMBP on a regular basis to guard
against the insidious onset of this disease.
Paul Pisarik, MD, MPH, Baylor College of Medicine,
Houston, Tex
Devices that meet standards 
for home BP measurement
SMBP device Validation protocol
suitable for 
home use
A&D-767 BHS
A&D-779 International Protocol
A&D-787 International Protocol
OMRON M5-I International Protocol
OMRON 705IT International Protocol
OMRON 705 CPII International Protocol
OMRON MIT BHS
Microlife 3BTO-A BHS
Microlife 3AG1 BHS
BHS: British Hypertension Society; International Protocol:
European Hypertension Society
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